1. Home
  2. BRID vs ELOX Comparison

BRID vs ELOX Comparison

Compare BRID & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgford Foods Corporation

BRID

Bridgford Foods Corporation

N/A

Current Price

$5.69

Market Cap

53.6M

ML Signal

N/A

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$14.51

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BRID
ELOX
Founded
1932
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
53.6M
60.3M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
BRID
ELOX
Price
$5.69
$14.51
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $38.25
AVG Volume (30 Days)
3.1K
★ 18.6K
Earning Date
08-24-2026
08-12-2026
Dividend Yield
★ 1.70%
N/A
EPS Growth
N/A
★ 41.67
EPS
★ N/A
N/A
Revenue
★ $174,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 4.21
N/A
52 Week Low
$5.34
$10.00
52 Week High
$8.62
$23.40

Technical Indicators

Market Signals
Indicator
BRID
ELOX
Relative Strength Index (RSI) 46.13 36.73
Support Level $5.65 $10.74
Resistance Level $6.23 $14.65
Average True Range (ATR) 0.17 1.35
MACD 0.01 -0.17
Stochastic Oscillator 45.10 8.05

Price Performance

Historical Comparison
BRID
ELOX

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: